Objective: To prospectively evaluate quality of life (QoL) evolution after robotic-assisted thoracoscopic or open anterior mediastinal tumour resection with the European Organisation for Research and Treatment of Cancer (EORTC) QoL Questionnaire-C30 and the lung cancer-specific module, LC-13. Methods: From January 2004 to December 2008, QoL was prospectively recorded in all patients undergoing surgery for mediastinal tumours. A total of 14 patients underwent thoracoscopic resection using the da Vinci robotic system (Intuitive Surgical, Inc., Mountain View, CA, USA), and 22 patients open resection through sternotomy. Questionnaires were administered before surgery and 1, 3, 6 and 12 months, postoperatively, with response rates of 100%, 86.1%, 94.4%; 75.0% and 86.1%, respectively. Results: Both approaches had comparable preoperative patients' characteristics and QoL subscales. Open resection by sternotomy was characterised by a significant decrease in general functioning 1 month after surgery (physical functioning p = 0.001, role functioning p = 0.001, and social functioning p = 0.044). Patients also complained of increased thoracic pain in the first 3 months after surgery ( p = 0.017). After a da Vinci robotic resection QoL scores approximated baseline preoperative values 1 month after surgery, with the exception of increase in thoracic and shoulder pain the first 3 months after surgery ( p = 0.028 and 0.029, respectively). Conclusions: Numerous techniques have been published with different degrees of invasiveness, generating the existing controversy as to which is the best surgical approach for anterior mediastinal tumours. The high burden of decreased physical functioning reported after sternotomy is not seen after a da Vinci robotic-assisted thoracoscopic resection. The initial experience and postoperative QoL data are excellent and, therefore, the da Vinci robot will stay our future technique of choice for the treatment of resectable mediastinal tumours smaller than 4 cm on imaging techniques. #
Introduction
The introduction of robotic-assisted surgical systems opened new possibilities in various surgical fields. Although the impact of robotic surgery on minimally invasive surgery is not yet clear, currently, it seems to be most promising for surgery in remote, narrow anatomical regions such as the mediastinum [1] . Although it has been postulated that minimally invasive mediastinal surgery, which avoids sternotomy, would reduce postoperative pain and accelerate postoperative recovery to a good quality of life (QoL) with no increase in operative mortality or complications, few data are currently available to document this intuitively appealing claim. The objective of the present study is to evaluate if the da Vinci robotic system used in mediastinal surgery has an advantage on patients' postoperative QoL compared with the traditional open technique.
Patients and methods
The use of the da Vinci robot (Intuitive Surgical, Inc., Mountain View, CA, USA) was introduced in the Antwerp University Hospital in 2004. From January 2004 to December 2008, 36 consecutive patients with a surgical resectable, anterior mediastinal mass were included. A total of 14 patients underwent a robotic-assisted thoracoscopic resection. As many as 22 patients, who were not considered for robotic-assisted surgery, underwent a conventional median sternotomy as approach for open resection. Exclusion criteria for robotic-assisted surgery were an anterior mediastinal mass with a maximal diameter of more than 4 cm on imaging techniques, inability to sustain single-lung ventilation and local invasiveness in the surrounding great vessels. All patients gave informed consent to participation and the study was approved by the institutional review board of the Antwerp University Hospital.
Surgical technique
2.1.1. Robotic-assisted anterior mediastinal mass resection 2.1.1.1. Anaesthesiology and patients' positioning. After general anaesthesia is initiated, patients are intubated with a double-lumen tube for selective single-lung ventilation. If access is made from the left side, the patient is positioned in an incomplete right-lateral decubitus with the left side elevated upwards at a 308 angle and the left arm parallel to the table on a lower level. The head is also tilted superiorly and slightly to the right.
2.1.1.2. Robotic system. The da Vinci robotic system consists of a master console, where the surgeon handles telemanipulators and optical controls using three-dimensional vision and the surgical arm cart, a manipulator unit with two instrument arms and a central arm to guide the twochannel endoscope. Specific robotic surgical instruments are introduced through special trocars and attached to the arms of the robot. The surgeon's movements on the handles are transmitted to the tips of the robotic instruments. The main technological advantages of this system are realistic threedimensional imaging, motion-scaling and tremor filtration. Robotic procedures are usually performed by two surgeons, the surgeon at the console and the tableside surgeon, who places the trocars and connects them with the robotic arms, changes the robotic instruments and manipulates additional non-robotic accessory instruments through the 4th auxiliary port, if needed. The robotic trocars are 10 mm for the binocular robotic camera and 8 mm for the instruments. A 08 or 308 endoscope is used. The second surgeon places the robotic ports in the lateral mammary fold with one hand's breadth between them, while the fourth port is placed more posteriorly, outside this circle.
2.1.1.3. Surgical technique. All anterior mediastinal tumours are resected by a direct left-or right-sided approach unless they are not visible within the thymic fat in which case they are resected by an extended thymectomy. Once CO 2 insufflation of 7 mm Hg is installed, dissection starts at the lower corner, anterior and medial to the phrenic nerve, and from here upwards alongside the nerve into the cervical region. Special attention is paid to the innominate vein and its thymic tributaries. These small veins are usually clipped through the fourth port by the second surgeon. The upper thymic poles are subsequently mobilised and, during this dissection, the innominate vein is compressed downwards by the second surgeon not to hurt it during dissection. In most cases, the contralateral pleura is opened to locate the phrenic nerve at the other side and to accomplish a complete extended thymectomy. The lower parts are dissected at the end, and, subsequently, the resected specimen is placed in an endobag and removed through the fourth trocar incision. A pleural drain is inserted through one of the ports crossing the mediastinum with its tip in the contralateral pleura, draining both thoracic cavities and the mediastinum.
Open mediastinal mass resection by sternotomy
With the patient under general anaesthesia, a sternotomy is performed. The mediastinum is thoroughly explored up to the cervical thymic extension and laterally down to the phrenic nerves. All thymic tissue and the entire pericardial and mediastinal fat, from the diaphragm to the thyroid, is removed en bloc. A thoracic drain is inserted, draining the mediastinum and the pleurae, if these are opened.
Postoperative recovery after both procedures
After surgery, all patients are extubated in the operating room whenever possible. The thoracic drain is removed when the underlying lung is fully expanded with no residual air leak and minimal drainage. Patients are discharged from the hospital when fully mobile and when their pain is controlled by oral analgesia.
Long-term QoL assessment
Long-term QoL was prospectively recorded using the Dutch version of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ)-C30 (cancer core questionnaire) and the EORTC QLQ-LC-13 lung cancer-specific questionnaire module. The EORTC QLQ-C30 (version 3.0) is a self-rating questionnaire composed of 30 questions/items and incorporates nine multi-item scales: five functional scales (physical, role, cognitive, emotional and social), three symptom scales (fatigue, pain and nausea/vomiting), a global health/QoL scale and several single items assessing additional symptoms (dyspnoea, sleep disturbance, constipation and diarrhoea). A final item evaluates the perceived economic consequences of the disease [2] . The EORTC QLQ-LC-13 is a supplementary questionnaire module and contains 13 questions/items assessing lung cancer-associated symptoms (cough, haemoptysis, dyspnoea and site-specific pain), chemotherapy/ radiotherapy-related side effects and pain medication [3] . Chemotherapy/radiotherapy-related side effects were not included in the analysis. Reliability and validity of the EORTC QLQ-C30 and LC-13 questionnaires have been confirmed in international cancer studies [2] [3] [4] . The questionnaires were administered 1 day before surgery and at 1, 3, 6 and 12 months, postoperatively. The questionnaires were sent to the patients by mail, accompanied by a letter with general information and the aim of the study.
Statistical analysis
Statistical analysis was performed using statistical software (SPSS, version 18.0, Chicago, IL, USA). In accordance with procedures recommended by the EORTC, scores were linearly converted to a scale ranging from 0 to 100 for each patient [2, 3] . For the functional scales, higher scores represent a higher level of functioning. For the symptom scales, higher scores represent a greater symptom burden. Non-parametric variables are reported as means with standard deviation, parametric variables as median with range. The Wilcoxon signed-rank test was used to compare the mean values before and after surgery. Student's t-test was used to compare parametric data between groups. To compare the QoL evolution between both groups, the difference between the baseline value and the value, postoperatively, was compared using the non-parametric Mann-Whitney U-test. A p value of less than 0.05 was considered as statistically significant. Table 1 outlines clinical demographics of patients for both procedure groups. Age, gender, duration of hospitalisation, total procedure duration, pathologic diagnosis of specimen and response rate to the QoL questionnaires were similar among both groups. Of the 36 patients, 22 patients returned all five questionnaires (61.1%), nine (25.0%) returned four, two (5.6%) returned three and three (8.3%) returned two questionnaires. There were no significant preoperative clinicopathological differences between patients, who returned all questionnaires, compared with those who did not. As was expected from the difference in indications between thoracoscopic and open resection, a significant difference was seen in maximal pathological diameter of the specimen, which was significantly higher in the sternotomy group (6.37 cm vs 10.32 cm; p = 0.005). The robotic-assisted resection was performed by a left-sided approach in nine patients (64.3%). CO 2 insufflation was used in nine patients (64.3%). Most robotic-assisted procedures were performed using four ports (12 procedures: 85.7%). In two patients (14.3%), only three ports were used. Myasthenia gravis (MG) was present in five patients of the robotic procedure group (35.7%) and in five patients in the sternotomy procedure group (22.7%) with comparable duration of MG symptoms before surgery (15.2 months and 6.2 months, respectively).
Results

Patient's and procedure characteristics
No intra-operative mortality or complications were experienced during the robotic procedure. One patient had a conversion to a median sternotomy because of ingrowth in the subclavian vein (7.1%). Postoperative complications included a phrenic nerve paralysis in two patients operated upon for a large thymic cyst (14.3%) and a deep-vein thrombosis in one (7.1%).
No intra-operative mortality or complications were seen during mediastinal mass resection by standard sternotomy approach. Postoperative complications included one cardiac tamponade (4.5%), one sternal instability necessitating refixation of the sternum (4.5%) and one keloid scar development (4.5%). Using a robotic-assisted approach, all patients had a macroscopically complete resection of the mediastinal mass. Because of microscopically limited resection margins, adjuvant postoperative radiotherapy was given to one patient, who underwent thymoma resection (7.1%). In the sternotomy approach group, six patients were treated with adjuvant radiotherapy because of advanced thymoma stage (27.3%). In the sternotomy group, there was one pleural recurrence of thymoma 54 months after surgery and adjuvant radiotherapy, necessitating re-operation by thoracotomy (4.5%).
QoL evolution after surgery
Before the procedure, patients complained of a moderately impaired global QoL, including role, social and emotional functioning. Patients also complained of fatigue, sleep disturbances, dyspnoea and appetite loss. Comparing both procedure groups, no significant differences were seen in the preoperative QoL subscale scores.
After the robotic-assisted procedure, all QoL subscales returned to baseline subscales 1 month after surgery, with the exception of a temporary increase in thoracic and shoulder pain in the first 3 months after surgery ( p = 0.028 and 0.029, respectively).
After the median sternotomy approach, a significant dip in general functioning was seen 1 month after surgery (physical functioning p = 0.001, role functioning p = 0.001 and social functioning p = 0.044), which was not seen after robotic surgery. Sternotomy patients complained of a 1-month temporary increase in fatigue ( p = 0.003) and a 3-month increase in thoracic pain ( p = 0.017). No significant differences in postoperative QoL data were seen between both procedures, with the exception of a significantly higher reported burden of shoulder discomfort at 12 months after a robotic-assisted procedure ( p = 0.012). QoL at baseline and evolution after both procedures is shown in Table 2 .
Discussion
The introduction of robotic surgical systems has added a new dimension to minimally invasive surgery. Although the impact of robotic surgery is not yet clear, currently, it seems to be most promising for surgery in remote, narrow anatomical regions [1] . Complete thymectomy is a crucial part of treatment for anterior mediastinal masses, such as MG and thymoma [5] . Advocates of robotic-assisted mediastinal surgery have postulated that by reducing incision size and overall operative trauma, it may be possible to decrease postoperative pain and improve QoL, translating into rapid recovery and the ability to resume preoperative activities more expeditiously. Although most studies of robotically assisted mediastinal surgery have reported morbidity and mortality [6] [7] [8] [9] , none have addressed outcome measures, such as QoL. The objective of the present study was to evaluate if the QoL after a robotic-assisted surgical approach, is comparable or superior to the standard sternotomy access. The results of the present prospective, non-randomised study show that although both patient groups had comparable preoperative characteristics except for tumour size, significant differences were seen in postoperative QoL evolution. After the robotic-assisted procedure, all functional QoL subscales returned to baseline subscales 1 month after surgery. By contrast, patients, who underwent a standard sternotomy, reported significant decreases in physical, role and social functioning 1 month after surgery. The incidence of chronic pain after sternotomy was evaluated by Kalso et al. [10] . Of 72 MG patients, who underwent thymectomy by conventional sternotomy, 27% reported chronic post-sternotomy pain, which was moderate to severe in 48% of the patients [10] . In the present study, patients reported significantly more thoracic pain the first 3 months after sternotomy. A robotic approach avoids the trauma of a sternotomy, which is of significant concern to many patients. However, patients in the robotic-assisted group complained also of thoracic pain and shoulder discomfort in the first 3 months, which can be explained by the use of intercostal trocars that may damage the intercostal nerves.
Robotic-assisted resections were preferentially performed by a left-sided approach with CO 2 insufflation to increase the retrosternal space in our center. We reserve the right-sided approach for small and lateral right-sided masses. In most of the right-sided cases CO 2 insufflation was not necessary. No significant difference was seen in total procedure time between both procedures. In this study, the timing of the procedure was expressed as total operating room occupation, also including anaesthetic preparation, set-up time of the robot and extubation after the procedure. This is in contrast to other publications, where only skin-toskin times are communicated. The rather long operating time of the sternotomy group may be explained by the large diameter of masses that were resected, necessitating more extensive dissection, and closure of the sternotomy incision.
Both procedures have specific complications. Although median sternotomy is often performed for several indications, it can lead to several specific complications as sternal instability and keloid scar formation, as in this study. In evaluating robotic-assisted mediastinal surgery, one may not forget that currently, a robotic approach does require more set-up time, is more costly, often requires two surgeons and lacks tactile feedback during dissection. The conversion to a median sternotomy in the present study, however, was not related to this lack of tactile feedback but because of invasiveness of the mediastinal mass in the surrounding vessels. The transient lesion of the left recurrent nerve, which occurred in two robotic procedures, was due to dissection of the nerve from the tumour's capsule and was not based on limitations of the robotic system.
There are several limitations in the present study. A valid and reliable measurement of QoL is of utmost importance. We evaluated QoL by the EORTC QLQ-C30 and LC-13 questionnaire. The reliability and validity of the EORTC questionnaires have only been confirmed in stage III and IV lung-cancer patients [2, 3] . It is unknown whether these standardised questionnaires are also applicable to patients with mediastinal pathology. However, the EORTC questionnaire has been used previously in evaluating QoL in post-thymectomy MG patients [11] . The size of the tumour has been proved to be the only limitation for the robotic approach [6] . The patients were not randomised between the two treatment groups, standard sternotomy being reserved for patients with larger mediastinal masses. Because of this, it is possible that patients undergoing the 'new' procedure, such as robotic surgery, were more likely to report positive postoperative experiences. Various approaches are available for the anterior mediastinum [12] [13] [14] [15] [16] [17] . Comparison of two minimally invasive approaches such as the conventional thoracoscopic and the robotic thoracoscopic approach might have provided even more meaningful results with regard to the effect of robotic technology. The objective of the present study was to evaluate if the QoL after a robotic-assisted surgical approach is comparable or superior to the standard sternotomy access, which is, at present, still the gold standard approach for the anterior mediastinum. In this study, robotic-assisted thoracoscopic resection of an anterior mediastinum mass was mostly performed for MG and small thymomas with a median follow-up time of 44 months. Different studies evaluated the long-term effects after thymectomy [11, 18] . In the study of Roth et al., the rate of the initial improvement decreased slightly, 13 years after transsternal thymectomy for MG [18] . Comparably, thymoma is a slowly growing tumour with recurrences that may occur 5-10 years following surgery [19] . As a result, the follow-up of new mediastinal surgical techniques has to be protracted to prove efficacy, despite the initial advantages of the minimally invasive approach. Notwithstanding these limitations, this study provides evidence that a robotically assisted procedure may confer important benefits, as improved postoperative QoL.
Conclusion
In conclusion, robotic-assisted thoracoscopic surgery of the anterior mediastinum and, particularly, thymectomy, can be performed safely and efficiently. The results of the present study suggest that robotic-assisted mediastinal surgical patients resume the routine activities of life more quickly than patients, who undergo standard sternotomy. Larger clinical studies with longer follow-up are required to substantiate this conclusion.
